Clinical Trial Update: Evaluation of Zotarolimus Eluting Stent at 3 Months Using Optical Coherence Tomography

View source ↗

Summary

A completed clinical trial evaluating the Zotarolimus-eluting stent with 3-month optical coherence tomography assessment in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Zotarolimus-eluting stent (zotarolimus)

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Disease | Status: COMPLETED